Published: August 12, 2016
Source: Corporate News Center, UTop Pharma
As UTop Pharma continues to advance the frontiers of peptide technology, 2016 marked another milestone — the company has officially entered the cosmetics raw material sector. UTop Pharma announced that its beauty peptide lyophilized powder has been successfully introduced into the supply chains of three leading domestic skincare brands, marking a significant leap from the pharmaceutical field into the broader beauty and personal care industry.
For nearly a decade, UTop Pharma has been recognized for its strength in pharmaceutical-grade peptide synthesis and lyophilization technology. Building on this solid foundation, the company identified growing demand for high-performance, biologically active ingredients in the cosmetics sector — particularly in anti-aging, skin repair, and barrier-strengthening formulations.
“Our expertise in peptide activity preservation and controlled lyophilization gave us a natural advantage in extending into skincare,” said the company’s Chief Technology Officer. “We realized that the principles ensuring peptide bioactivity in pharmaceuticals could be reimagined for cosmetic formulations — with a focus on purity, safety, and sensory experience.”
UTop Pharma’s R&D team undertook a comprehensive program to adapt its existing pharmaceutical processes to meet the needs of the cosmetics industry. The result was a new generation of cosmetic-grade lyophilized peptide ingredients designed for both efficacy and formulation compatibility.
Key technological adaptations include:
Purity optimization: Achieving >99% peptide purity through multi-step chromatography, ensuring clear appearance and high stability in cosmetic emulsions;
Enhanced solubility: Reformulating peptide protection systems to enable rapid dissolution in neutral pH buffers and cosmetic bases;
Mildness and stability: Eliminating reactive residues and optimizing freeze-drying curves to maintain stability even under high-temperature storage and long-term exposure.
These improvements allowed UTop Pharma’s beauty peptides to meet both EU Cosmetic Regulation standards and China’s safety evaluation protocols, creating a seamless transition from medical-grade reliability to skincare-grade comfort.
Within six months of pilot production, UTop Pharma’s cosmetic peptides were successfully integrated into the formulation pipelines of three major domestic skincare companies, covering applications in anti-aging serums, firming essences, and post-procedure repair masks.
Feedback from partners has highlighted the ingredient’s superior activity retention and elegant skin feel. The partnerships demonstrate market confidence in UTop Pharma’s ability to provide stable, traceable, and high-performance peptide raw materials for the fast-growing beauty market.
“This collaboration marks the beginning of a new growth curve,” noted the company’s Business Development Director. “We are not simply entering a new industry — we are redefining how pharmaceutical-grade science can empower beauty.”
The successful crossover into the cosmetics field represents a strategic diversification of UTop Pharma’s business model. While continuing to serve global pharmaceutical partners, the company is now positioned to capture the surging demand in the cosmeceutical and active ingredient markets — sectors characterized by rapid innovation and high value addition.
UTop Pharma plans to:
Establish a dedicated Beauty Peptide Application Laboratory for customized formulation testing;
Launch joint development programs with domestic and international skincare brands;
Expand production capacity for cosmetic-grade lyophilized ingredients to support large-scale, stable supply.
The company views its entry into beauty peptides not as a detour, but as a natural extension of its scientific mission — translating biotechnology into everyday well-being.
“In pharmaceuticals, we repair from within; in cosmetics, we rejuvenate from without,” Dr. Zhang, the founder of UTop Pharma, concluded. “Both share the same pursuit — using the precision of peptide science to enhance the quality of life.”
The success of this strategic expansion marks UTop Pharma’s evolution from a manufacturer of peptide intermediates to a multi-industry innovation platform, bridging medicine, health, and beauty.
Issued by: Corporate News Center
Editor: Corporate Branding Department
Date: August 12, 2016
